Leading the way
in global diagnostics
ACON Laboratories makes Point-of-care medical diagnostics affordable to people all around the world. We provide rapid diagnostics and healthcare products based on a philosophy of high quality, affordability and superior flexibility.
Our Brands

Blood Glucose Meter Systems
Carefully designed for accuracy and reliability, the On Call® Blood Glucose Meter Family has helped millions of patients worldwide effectively manage their glucose levels.

Point-of-care testing (POCT)
Our product offering includes a variety of urine reagent test strips, urine analyzers and handheld devices for the measurement of cholesterol, coagulation and hemoglobin.

Urinary Tract Infection (UTI)
ACON Labs has been the leading UTI manufacturer in the US. The HealthyMe Urinary Tract Infection reagent strips are highly reliable and easy to use.

Lateral Flow Rapid Tests
Reliable qualitative screening for Pregnancy, Cancer Markers and Infectious Disease including our SARS-CoV-2 (COVID-19) antibody test.

Our Newest Brand
FlowflexTM is the newest brand addition to the ACON product portfolio. The Flowflex SARS-CoV-2 Rapid Antigen Test is the first in this family of lateral flow testing products.

Pregnancy Rapid Tests
Rapid chromatographic immunoassays for the qualitative detection of human chorionic gonadotropin (hCG) in urine.

Allergen Test Kit
This tried-and-true immunoblot assay tests for 30 allergens on one strip.

Molecular Diagnostics
Nucleic Acid Extraction System and PCR quantitative test kits for HBV, HCV, HPV 16/18, HPV Genotyping, TB and HLA-B27.

Animal Health
Our product offering includes a dual Ketone/Glucose meter, as well as urine reagent test strips.
News and Press Releases
ACON Receives FDA 510(k) Clearance for Flowflex® COVID-19 Test; Will be Manufactured in San Diego
SAN DIEGO, CA, November 9, 2023 – ACON Laboratories, Inc. is proud to announce that the U.S. Food & Drug Administration (FDA) has granted 510(k) marketing clearance for the Flowflex® COVID-19 Antigen Home Test. This is the first FDA 510(k) for an over-the-counter...
Recall Issued by the Philadelphia Department of Public Health for Counterfeit Flowflex COVID-19 Tests
ACON Laboratories, Inc. is aware of the announcement by the Philadelphia Department of Public Health of a recall of certain at-home COVID-19 tests on September 9, 2023, and actively working with them and the FDA to conduct further investigation. The Lot number of...
ACON Laboratories, Inc. Announces the Launch of On Call® MultiPro
HbA1c, ACR and CRP Now Available in Europe and Latin America San Diego — August 30, 2023, ACON Laboratories, Inc. announced availability of the On Call® MultiPro System for point-of-care testing in physician offices, clinics and hospitals. The system features...
STATEMENT ON THE OMICRON EG.5 and FL.1.5.1 VARIANT
ACON Laboratories, Inc. has been continuously monitoring the emergence of SARS-CoV-2 variants. According to the Centers for Disease Control and Prevention (CDC) COVID Data Tracker, the Omicron variant remains the dominant variant circulating in the United States,...